Umoja Biopharma
June 18, 2025
Company Presentation
Cell and Gene Therapy and Genome Editing
153A
Umoja Biopharma is a clinical stage, in vivo CAR T cell therapy developer and manufacturer
Company HQ City:
Seattle
Company HQ State:
WA
Company HQ Country:
United States
Year Founded:
2019
Lead Product in Development:
UB-VV111, UB-VV400
CEO
Andrew Scharenberg
Development Phase of Lead Product
Phase I
When you expect your next catalyst update?
FIH clinical data
What is your next catalyst (value inflection) update?
December 2025
Website
umoja-biopharma.com
Speakers
.jpg)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}